"The Cancer Care Northwest South Spokane Clinic offers a complete range of integrated services, including PET/CT scans, chemotherapy treatment, surgical oncology, lab work and follow-up care. The clinic’s physicians specialize in medical hematology/oncology and surgical oncology, including one of the region’s best breast surgeons. The staff also includes a wide-variety of specialists that provide support services for patients. For four decades, cancer patients and their families have trusted Cancer Care Northwest as their partner in their fight against cancer. Why? Better All-Around, Compassionate Care Here, you get more than medical excellence. We are a place of healing, warmth and kindness."

During the past decade, Cancer Care Northwest conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 17 clinical trials were completed, i.e. on average, 106.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Northwest" #1 sponsor was "Point Therapeutics" with 5 trials, followed by "Galera Therapeutics, Inc." with 4 trials sponsored, "Gradalis, Inc." with 4 trials sponsored, "Astellas Pharma Inc" with 3 trials sponsored and "Dendreon" with 3 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Northwest" #1 collaborator was "OSI Pharmaceuticals" with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cell Pathways" with 1 trials as a collaborator and "Eisai Limited" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Northwest" are "Metastatic Breast Cancer" (7 trials), "Multiple Myeloma" (5 trials), "Breast Cancer" (4 trials), "Lung Cancer" (4 trials) and "Carcinoma, Non-Small-Cell Lung" (3 trials). Many other conditions were trialed in "Cancer Care Northwest" in a lesser frequency.

Most popular intervention types in "Cancer Care Northwest" are "Drug" (50 trials), "Biological" (11 trials), "Radiation" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Cyclophosphamide" (3 trials), "Doxorubicin" (3 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (2 trials) and "Daratumumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Northwest" are 48 trials for "All" genders, 10 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Care Northwest". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Cancer Care Northwest, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Northwest, 10 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Cancer Care Northwest has several departments that took part in Clinical trials: "Cancer Care Northwest - Spokane South" - 205 trials, "Cancer Care Northwest-North Spokane" - 34 trials, "Cancer Care Northwest-Valley" - 34 trials, "North Idaho Cancer Center" - 20 trials, "Cancer Care Northwest CC Northwest- Spokane South(3)" - 2 trials